We believe that leg lengthening can be cheaper and much more comfortable than before. Any day now, we will start clinical trials, which we strongly believe will confirm the effectiveness
and innovation of the technology that makes up OrthoSystem and will allow us to bring our product to market as early as 2024.
President Dominika Grygier and CEO Robert Jastrząbek, PhD, told Business Pulse about the plans for the near future:
“To complete clinical trials, certification and start commercialization, we currently need about PLN 3.6 million. We want to raise half of this amount by June and the rest by November. Cash is crucial for us in this round, but the investor’s industry expertise will be an additional asset,” the start-up’s heads said in an interview with editor Mariusz Bartodziej.
Orthoget has so far received more than PLN 6 million in funding from the NCBiR and about PLN 3.5 million from investment funds and business angels.
The entire article can be found here: https://lnkd.in/d2hVpnSP